Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 272

1.

Serum markers support disease-specific glial pathology in major depression.

Schroeter ML, Abdul-Khaliq H, Krebs M, Diefenbacher A, Blasig IE.

J Affect Disord. 2008 Dec;111(2-3):271-80. doi: 10.1016/j.jad.2008.03.005. Epub 2008 Apr 21.

PMID:
18430474
2.

Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia--original research and meta-analysis.

Schroeter ML, Abdul-Khaliq H, Krebs M, Diefenbacher A, Blasig IE.

Psychiatry Res. 2009 May 15;167(1-2):66-72. doi: 10.1016/j.psychres.2008.01.002. Epub 2009 Apr 16.

PMID:
19375171
3.

Glial pathology is modified by age in mood disorders--a systematic meta-analysis of serum S100B in vivo studies.

Schroeter ML, Steiner J, Mueller K.

J Affect Disord. 2011 Nov;134(1-3):32-8. doi: 10.1016/j.jad.2010.11.008. Epub 2010 Dec 8.

PMID:
21144594
4.

S100B is increased in mood disorders and may be reduced by antidepressive treatment.

Schroeter ML, Abdul-Khaliq H, Diefenbacher A, Blasig IE.

Neuroreport. 2002 Sep 16;13(13):1675-8.

PMID:
12352625
5.

Serum S100B represents a new biomarker for mood disorders.

Schroeter ML, Sacher J, Steiner J, Schoenknecht P, Mueller K.

Curr Drug Targets. 2013 Oct;14(11):1237-48. Review.

6.

Mood disorders are glial disorders: evidence from in vivo studies.

Schroeter ML, Abdul-Khaliq H, Sacher J, Steiner J, Blasig IE, Mueller K.

Cardiovasc Psychiatry Neurol. 2010;2010:780645. doi: 10.1155/2010/780645. Epub 2010 May 27.

7.

Elevated serum S100B protein and neuron-specific enolase levels in carbon monoxide poisoning.

Yardan T, Cevik Y, Donderici O, Kavalci C, Yilmaz FM, Yilmaz G, Vural K, Yuzbasioglu Y, Gunaydin YK, Sezer AA.

Am J Emerg Med. 2009 Sep;27(7):838-42. doi: 10.1016/j.ajem.2008.04.016.

PMID:
19683113
8.

Brain injury markers (S100B and NSE) in chronic cocaine dependents.

Kessler FH, Woody G, Portela LV, Tort AB, De Boni R, Peuker AC, Genro V, von Diemen L, de Souza DO, Pechansky F.

Rev Bras Psiquiatr. 2007 Jun;29(2):134-9.

PMID:
17650535
9.

Serum concentrations of s100b and NSE in migraine.

Teepker M, Munk K, Mylius V, Haag A, Möller JC, Oertel WH, Schepelmann K.

Headache. 2009 Feb;49(2):245-52. doi: 10.1111/j.1526-4610.2008.01228.x. Epub 2009 Sep 9.

PMID:
18783450
10.

S100B and response to treatment in major depression: a pilot study.

Arolt V, Peters M, Erfurth A, Wiesmann M, Missler U, Rudolf S, Kirchner H, Rothermundt M.

Eur Neuropsychopharmacol. 2003 Aug;13(4):235-9.

PMID:
12888182
11.

S100B-immunopositive astrocytes and oligodendrocytes in the hippocampus are differentially afflicted in unipolar and bipolar depression: a postmortem study.

Gos T, Schroeter ML, Lessel W, Bernstein HG, Dobrowolny H, Schiltz K, Bogerts B, Steiner J.

J Psychiatr Res. 2013 Nov;47(11):1694-9. doi: 10.1016/j.jpsychires.2013.07.005. Epub 2013 Jul 26.

PMID:
23896207
12.

S100B and NSE serum levels in patients with Parkinson's disease.

Schaf DV, Tort AB, Fricke D, Schestatsky P, Portela LV, Souza DO, Rieder CR.

Parkinsonism Relat Disord. 2005 Jan;11(1):39-43.

PMID:
15619461
13.

Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury.

Geyer C, Ulrich A, Gräfe G, Stach B, Till H.

J Neurosurg Pediatr. 2009 Oct;4(4):339-44. doi: 10.3171/2009.5.PEDS08481.

PMID:
19795965
14.

Validating serum S100B and neuron-specific enolase as biomarkers for the human brain - a combined serum, gene expression and MRI study.

Streitbürger DP, Arelin K, Kratzsch J, Thiery J, Steiner J, Villringer A, Mueller K, Schroeter ML.

PLoS One. 2012;7(8):e43284. doi: 10.1371/journal.pone.0043284. Epub 2012 Aug 14.

15.

Elevated S100B and neuron specific enolase levels in patients with migraine-without aura: evidence for neurodegeneration?

Yilmaz N, Karaali K, Ozdem S, Turkay M, Unal A, Dora B.

Cell Mol Neurobiol. 2011 May;31(4):579-85. doi: 10.1007/s10571-011-9651-z. Epub 2011 Feb 4.

PMID:
21293918
16.
17.

Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder.

Schmidt FM, Mergl R, Stach B, Jahn I, Schönknecht P.

World J Biol Psychiatry. 2015 Feb;16(2):106-13. doi: 10.3109/15622975.2014.952776. Epub 2014 Sep 29.

PMID:
25264292
18.

Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes.

Hamidi M, Drevets WC, Price JL.

Biol Psychiatry. 2004 Mar 15;55(6):563-9.

PMID:
15013824
19.

Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children.

Berger RP, Adelson PD, Pierce MC, Dulani T, Cassidy LD, Kochanek PM.

J Neurosurg. 2005 Jul;103(1 Suppl):61-8.

PMID:
16122007
20.

The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment.

Hetzel G, Moeller O, Evers S, Erfurth A, Ponath G, Arolt V, Rothermundt M.

Psychopharmacology (Berl). 2005 Mar;178(2-3):161-6. Epub 2004 Aug 14.

PMID:
15316717
Items per page

Supplemental Content

Write to the Help Desk